Cancer · March 25, 2026
First Targeted Therapy Approved for Debilitating Rare Blood Disorder
The first FDA-approved treatment for a rare blood cancer marks a major milestone in addressing a previously untreatable disease....
Cancer · March 23, 2026
New FDA Guidance Accelerates Myeloma Drug Approvals and Patient Access
Researchers achieve significant progress in developing new myeloma treatments....